Hemas Holdings PLC (HHL) - 2Q FY25 - BUY
Loading...
Earnings Reviews
03/12/2024
326
0
We maintain our BUY rating with an intrinsic value of LKR 113 based on SOTP valuation. We remain bullish on HHL’s Healthcare sector in the near to medium term while a recovery in Consumer Brands is expected with improved consumer spending.
Discussion (0)
Latest Reports
Free
Related Reports
Free
You must login to post a comment.